While we did not observe any significant differences between activities of tADA (Figure 2A) and ADA1 (Figure 2B) or ADA2 (Figure 2C) alone in the CSF between MS patients and the control group, the ratio of ADA1:ADA2 was increased in the MS group (Figure 2D). Here, ADA2 is linked to myeloid sarcoma.